First Light Asset Management, LLC

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001600004
Type: FundHoldings: 37Value: $875.7MLatest: 2025Q1

First Light Asset Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 37 holdings worth $0.9 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
37
Total Value
875711490
Accession Number
0001999371-25-006243
Form Type
13F-HR
Manager Name
First-Light-Asset-Management
Data Enrichment
95% identified
35 identified2 unidentified

Holdings

37 positions • $875.7M total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
ANAPTYSBIO, INC
Shares:4.6M
Value:$86.1M
% of Portfolio:9.8% ($86.1M/$875.7M)
Axogen, Inc.
Shares:4.5M
Value:$82.8M
% of Portfolio:9.5% ($82.8M/$875.7M)
Centessa Pharmaceuticals plc
Shares:4.9M
Value:$70.1M
% of Portfolio:8.0% ($70.1M/$875.7M)
NEOGENOMICS INC
Shares:6.0M
Value:$57.3M
% of Portfolio:6.5% ($57.3M/$875.7M)
Twist Bioscience Corp
Shares:1.2M
Value:$47.8M
% of Portfolio:5.5% ($47.8M/$875.7M)
Health Catalyst, Inc.
Shares:10.4M
Value:$47.3M
% of Portfolio:5.4% ($47.3M/$875.7M)
AtriCure, Inc.
Shares:1.3M
Value:$42.4M
% of Portfolio:4.8% ($42.4M/$875.7M)
Edgewise Therapeutics, Inc.
Shares:1.9M
Value:$40.8M
% of Portfolio:4.7% ($40.8M/$875.7M)
Performant Healthcare Inc
Shares:11.7M
Value:$34.6M
% of Portfolio:4.0% ($34.6M/$875.7M)
iRhythm Technologies, Inc.
Shares:325.0K
Value:$34.0M
% of Portfolio:3.9% ($34.0M/$875.7M)
Crinetics Pharmaceuticals, Inc.
Shares:855.4K
Value:$28.7M
% of Portfolio:3.3% ($28.7M/$875.7M)
Vera Therapeutics, Inc.
Shares:1.2M
Value:$28.2M
% of Portfolio:3.2% ($28.2M/$875.7M)
MIMEDX GROUP, INC.
Shares:3.5M
Value:$26.2M
% of Portfolio:3.0% ($26.2M/$875.7M)
Ultragenyx Pharmaceutical Inc.
Shares:632.0K
Value:$22.9M
% of Portfolio:2.6% ($22.9M/$875.7M)
SI-BONE, Inc.
Shares:1.6M
Value:$22.6M
% of Portfolio:2.6% ($22.6M/$875.7M)
Xenon Pharmaceuticals Inc.
Shares:627.9K
Value:$21.1M
% of Portfolio:2.4% ($21.1M/$875.7M)
NeuroPace Inc
Shares:1.6M
Value:$19.5M
% of Portfolio:2.2% ($19.5M/$875.7M)
Alignment Healthcare, Inc.
Shares:956.4K
Value:$17.8M
% of Portfolio:2.0% ($17.8M/$875.7M)
Janux Therapeutics, Inc.
Shares:658.8K
Value:$17.8M
% of Portfolio:2.0% ($17.8M/$875.7M)
ESTABLISHMENT LABS HOLDINGS INC.
Shares:336.9K
Value:$13.7M
% of Portfolio:1.6% ($13.7M/$875.7M)